Beraprost (United Therapeutics/Astellas/Kaken Pharmaceutical Co) is an oral chemically stable prostacyclin analog targeting the prostaglandin I2 (PGI2) receptor…
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!